Cargando…

Low-dose ionizing radiation as a hormetin: experimental observations and therapeutic perspective for age-related disorders

Hormesis is any kind of biphasic dose-response when low doses of some agents are beneficial while higher doses are detrimental. Radiation hormesis is the most thoroughly investigated among all hormesis-like phenomena, in particular in biogerontology. In this review, we aimed to summarize research ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaiserman, Alexander, Cuttler, Jerry M., Socol, Yehoshua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794644/
https://www.ncbi.nlm.nih.gov/pubmed/33420860
http://dx.doi.org/10.1007/s10522-020-09908-5
_version_ 1783634258455166976
author Vaiserman, Alexander
Cuttler, Jerry M.
Socol, Yehoshua
author_facet Vaiserman, Alexander
Cuttler, Jerry M.
Socol, Yehoshua
author_sort Vaiserman, Alexander
collection PubMed
description Hormesis is any kind of biphasic dose-response when low doses of some agents are beneficial while higher doses are detrimental. Radiation hormesis is the most thoroughly investigated among all hormesis-like phenomena, in particular in biogerontology. In this review, we aimed to summarize research evidence supporting hormesis through exposure to low-dose ionizing radiation (LDIR). Radiation-induced longevity hormesis has been repeatedly reported in invertebrate models such as C. elegans, Drosophila and flour beetles and in vertebrate models including guinea pigs, mice and rabbits. On the contrary, suppressing natural background radiation was repeatedly found to cause detrimental effects in protozoa, bacteria and flies. We also discussed here the possibility of clinical use of LDIR, predominantly for age-related disorders, e.g., Alzheimer’s disease, for which no remedies are available. There is accumulating evidence that LDIR, such as those commonly used in X-ray imaging including computer tomography, might act as a hormetin. Of course, caution should be exercised when introducing new medical practices, and LDIR therapy is no exception. However, due to the low average residual life expectancy in old patients, the short-term benefits of such interventions (e.g., potential therapeutic effect against dementia) may outweigh their hypothetical delayed risks (e.g., cancer). We argue here that assessment and clinical trials of LDIR treatments should be given priority bearing in mind the enormous economic, social and ethical implications of potentially-treatable, age-related disorders.
format Online
Article
Text
id pubmed-7794644
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-77946442021-01-11 Low-dose ionizing radiation as a hormetin: experimental observations and therapeutic perspective for age-related disorders Vaiserman, Alexander Cuttler, Jerry M. Socol, Yehoshua Biogerontology Review Article Hormesis is any kind of biphasic dose-response when low doses of some agents are beneficial while higher doses are detrimental. Radiation hormesis is the most thoroughly investigated among all hormesis-like phenomena, in particular in biogerontology. In this review, we aimed to summarize research evidence supporting hormesis through exposure to low-dose ionizing radiation (LDIR). Radiation-induced longevity hormesis has been repeatedly reported in invertebrate models such as C. elegans, Drosophila and flour beetles and in vertebrate models including guinea pigs, mice and rabbits. On the contrary, suppressing natural background radiation was repeatedly found to cause detrimental effects in protozoa, bacteria and flies. We also discussed here the possibility of clinical use of LDIR, predominantly for age-related disorders, e.g., Alzheimer’s disease, for which no remedies are available. There is accumulating evidence that LDIR, such as those commonly used in X-ray imaging including computer tomography, might act as a hormetin. Of course, caution should be exercised when introducing new medical practices, and LDIR therapy is no exception. However, due to the low average residual life expectancy in old patients, the short-term benefits of such interventions (e.g., potential therapeutic effect against dementia) may outweigh their hypothetical delayed risks (e.g., cancer). We argue here that assessment and clinical trials of LDIR treatments should be given priority bearing in mind the enormous economic, social and ethical implications of potentially-treatable, age-related disorders. Springer Netherlands 2021-01-09 2021 /pmc/articles/PMC7794644/ /pubmed/33420860 http://dx.doi.org/10.1007/s10522-020-09908-5 Text en © The Author(s), under exclusive licence to Springer Nature B.V. part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review Article
Vaiserman, Alexander
Cuttler, Jerry M.
Socol, Yehoshua
Low-dose ionizing radiation as a hormetin: experimental observations and therapeutic perspective for age-related disorders
title Low-dose ionizing radiation as a hormetin: experimental observations and therapeutic perspective for age-related disorders
title_full Low-dose ionizing radiation as a hormetin: experimental observations and therapeutic perspective for age-related disorders
title_fullStr Low-dose ionizing radiation as a hormetin: experimental observations and therapeutic perspective for age-related disorders
title_full_unstemmed Low-dose ionizing radiation as a hormetin: experimental observations and therapeutic perspective for age-related disorders
title_short Low-dose ionizing radiation as a hormetin: experimental observations and therapeutic perspective for age-related disorders
title_sort low-dose ionizing radiation as a hormetin: experimental observations and therapeutic perspective for age-related disorders
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794644/
https://www.ncbi.nlm.nih.gov/pubmed/33420860
http://dx.doi.org/10.1007/s10522-020-09908-5
work_keys_str_mv AT vaisermanalexander lowdoseionizingradiationasahormetinexperimentalobservationsandtherapeuticperspectiveforagerelateddisorders
AT cuttlerjerrym lowdoseionizingradiationasahormetinexperimentalobservationsandtherapeuticperspectiveforagerelateddisorders
AT socolyehoshua lowdoseionizingradiationasahormetinexperimentalobservationsandtherapeuticperspectiveforagerelateddisorders